TABLE 1.
Characteristics of the study population.
| Traits | Data sources | Case/control | Sample size | Population | Gender | F statistic (total) |
|---|---|---|---|---|---|---|
| Exposure | ||||||
| Inflammatory bowel disease | IIBDGC | 31,665/33977 | 65,642 | European | Males and Females | 806.77 |
| Crohn's disease | IIBDGC | 17,897/33977 | 51,874 | European | Males and Females | 1574.42 |
| Ulcerative colitis | IIBDGC | 13,768/33977 | 47,745 | European | Males and Females | 1044.86 |
| Inflammatory bowel disease | IIBDGC | 2824/3719 | 6543 | East Asian | Males and Females | 524.38 |
| Crohn's disease | IIBDGC | 1690/3719 | 5409 | East Asian | Males and Females | 6808.17 |
| Ulcerative colitis | IIBDGC | 1134/3719 | 4853 | East Asian | Males and Females | 691.50 |
| Outcome | ||||||
| Hepatocellular carcinoma | UK Biobank | 168/372016 | 372,184 | European | Males and Females | NA |
| Cholangiocarcinoma | UK Biobank | 350/372016 | 372,366 | European | Males and Females | NA |
| Pancreatic cancer | PanScan1 | 1896/1939 | 3835 | European | Males and Females | NA |
| Hepatocellular carcinoma | BioBank Japan | 1866/195745 | 197,611 | East Asian | Males and Females | NA |
| Cholangiocarcinoma | BioBank Japan | 339/195745 | 196,084 | East Asian | Males and Females | NA |
| Pancreatic cancer | BioBank Japan | 442/195745 | 196,187 | East Asian | Males and Females | NA |